Conflict of Interest in Psychopharmacology: Can Dr. Jekyll Still Control Mr. Hyde?
- 12 December 2003
- journal article
- editorial
- Published by S. Karger AG in Psychotherapy and Psychosomatics
- Vol. 73 (1) , 1-4
- https://doi.org/10.1159/000074433
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- ReplyPsychotherapy and Psychosomatics, 2003
- Use of Antidepressant Medications and the Possible Association with Breast Cancer RiskPsychotherapy and Psychosomatics, 2003
- Lines of Evidence on the Risks of Suicide with Selective Serotonin Reuptake InhibitorsPsychotherapy and Psychosomatics, 2003
- Opportunistic ‘Rediscovery’ of Mental Disorders by the Pharmaceutical IndustryPsychotherapy and Psychosomatics, 2002
- Treatment Approaches to Major Depressive Disorder RelapsePsychotherapy and Psychosomatics, 2002
- Tolerance in Antidepressant TreatmentPsychotherapy and Psychosomatics, 2002
- Some Thoughts fromYour PublisherPsychotherapy and Psychosomatics, 2002
- Journal Policies on Conflict of Interest: If this Is the Therapy, What’s the Disease?Psychotherapy and Psychosomatics, 2001
- Conflict of Interest and Special Interest GroupsPsychotherapy and Psychosomatics, 2001
- All Our Dreams Are SoldPsychotherapy and Psychosomatics, 1998